|BIOTECHNOLOGY - NEUROSCIENCE|
|The Genetic Point of Care: the New Frontier of Bio-Technologies for Future Outbreaks Management|
|Co-organized with University of Messina, Polytechnic of Turin and FBK|
The the pandemic infection caused by SARS-CoV-2 virus, currently affecting worldwide more than 129 million of people with more than 3 million of deaths (WHO March 28th, 2021 weekly report), has dramatically highlighted the importance of availability of technologies allowing rapid molecular diagnostic tests for timely prevention and control of outbreak.
In this context, the genetic point-of-care technologies (POCT) becomes very relevant offering the advantages to be fast, sensitive and specific, low cost and, above all, able to be used on-site by not-specialized people. Recent progresses in the development of POC devices including lab-on-a-chip (LOC) devices, lab-on-a-disc (LOAD) devices, miniaturized PCR devices, isothermal nucleic acid amplification (INAA) devices, microfluidic paper-based analytical devices (μPADs) and lateral flow devices. In this Special Session an overview of most innovative approaches for genetic point care technologies rapid test will be presented and discussed in a dedicated round table.
|Back to Thematic Workshops & Symposia|